Sri Priyanka Geo Commex IPO

The company's international Barite and Fluorspar business is conducted through its Singapore subsidiary, Geo Min Commodities Pte. Ltd., and Geo Min's step-down subsidiary in Morocco, Atlas Resources International. It also procures Copper Cathode from Chile and sells it through Geo Min Commodities Pte. Ltd.

The rice bran oil division produces crude and refined rice bran oil at a manufacturing facility in Andhra Pradesh, with an existing capacity of 60,000 MT per annum for the Solvent Extraction Plant and 15,000 MT per annum for the oil refinery; the company also generates by-products such as De-Oiled Rice Bran, gums, and wax.

In Fiscal 2025, the company sold commodities across 7 Indian states and 5 international markets. The company is led by promoters Venkata Sai Shiv Prasad Nuthalapati, Ravi Kumar Nuthalapati, and Veera Vikram Nuthalapati.

Competitive strengths cited include diversified and de-risked business operations across a large and growing addressable market, strategically located operational hubs for supply chain efficiency, a fully automated manufacturing unit with a strong quality focus, long-term and optimized procurement arrangements for barite and fluorspar from Moroccan miners, and long-term supply arrangements with a well-diversified customer base.

The issue is entirely a fresh issue of 44,58,000 shares aggregating up to ₹95 Cr, with no offer-for-sale component. Net proceeds are earmarked for loan prepayment/repayment (₹10.00 Cr), working capital for the Company (₹16.50 Cr), working capital funding for its Singapore subsidiary Geo Min Commodities Pte. Ltd. (₹47.00 Cr), and general corporate purposes (amount unstated); promoter holding will fall from 100% pre-issue to 72.54% post-issue.

At the upper price band, the post-issue P/E works out to 14.54x, down from a pre-issue P/E of 25.42x, indicating the issue is priced at a discount to where the company traded pre-IPO. Debt/Equity has improved from 1.11x (Mar 2025) to 1.04x (Dec 2025), and profitability metrics are strong, with ROE at 42.86%, ROCE at 46.17%, and RONW at 34.78% as of December 2025.

Revenue, EBITDA, and PAT have all shown a strong upward trajectory from FY23 through the 9-month period ended December 2025, with PAT margin nearly doubling from 3.69% to 7.15% and EBITDA margin improving from 6.18% to 10.53% over the same comparison. No peer comparison or recently-listed-sector data, and no broker or message-board review commentary, is available in the source to benchmark sentiment, and a notable portion of proceeds (₹47 Cr) is directed toward funding the Singapore subsidiary's working capital rather than the core Indian operations, which investors may want to weigh as a risk factor.